Inventor · disambiguated record
John C. Cambier
Also filed as: CAMBIER JOHN · CAMBIER JOHN C
8 granted patents·9 pending applications·52 citations·filing 2000–2022
86Inventor score
Files withNAT JEWISH HEALTH7CAMBIER JOHN C3Nepenthe Bioscience LLC2NAT JEWISH MED & RES CENTER1NAT JEWISH MEDICAL & RES CT &1
Top patents by PatentIndex Score
17 records- 0195US10760055B2Conditionally immortalized long-term stem cells and methods of making and using such cellsNAT JEWISH HEALTH·Filed 2018·Granted Sep 1, 2020·8 cites·8 claims
- 0291US9150831B2Conditionally immortalized long-term stem cells and methods of making and using such cellsCAMBIER JOHN C·Filed 2010·Granted Oct 6, 2015·19 cites·9 claims
- 0385US7825224B2Product and method for treatment of conditions associated with receptor-desensitizationNAT JEWISH HEALTH·Filed 2007·Granted Nov 2, 2010·9 cites·7 claims
- 0480US2022145253A1Conditionally immortalized long-term stem cells and methods of making and using such cellsNAT JEWISH HEALTH·Filed 2022·Application pending·0 cites
- 0578US6503509B1Method for receptor desensitizationNAT JEWISH MEDICAL & RES CT·Filed 2000·Granted Jan 7, 2003·14 cites·18 claims
- 0674US11078276B2Anti-CD79 antibodies and their usesNepenthe Bioscience LLC·Filed 2019·Granted Aug 3, 2021·1 cites·13 claims
- 0774US8883507B2Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cellsCAMBIER JOHN C·Filed 2006·Granted Nov 11, 2014·1 cites·14 claims
- 0874US2020308545A1Conditionally immortalized long-term stem cells and methods of making and using such cellsNAT JEWISH HEALTH·Filed 2020·Application pending·0 cites
- 0967US9796961B2Conditionally immortalized long-term stem cells and methods of making and using such cellsNAT JEWISH HEALTH·Filed 2014·Granted Oct 24, 2017·0 cites·9 claims
- 1058US2021355214A1Anti-CD79 Antibodies and Their UsesNepenthe Bioscience LLC·Filed 2021·Application pending·0 cites
- 1158US2016040129A1Conditionally immortalized long-term stem cells and methods of making and using such cellsNAT JEWISH HEALTH·Filed 2015·Application pending·0 cites
- 1252US11701361B2p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an immune response to exogenous immunogensUNIV COLORADO REGENTS·Filed 2019·Granted Jul 18, 2023·0 cites·10 claims
- 1351US2004229354A1Enhancement of humoral immune responses using a novel myeloid accessory cellFiled 2004·Application pending·0 cites
- 1451US2011212111A1MHC II Associated Protein and Uses ThereofCAMBIER JOHN C·Filed 2009·Application pending·0 cites
- 1551US2011097327A1Product and method for treatment of conditions associated with receptor-desensitizationNAT JEWISH HEALTH·Filed 2010·Application pending·0 cites
- 1650US2003077284A1Product and method for treatment of conditions associated with receptor-desensitizationNAT JEWISH MED & RES CENTER·Filed 2002·Application pending·0 cites
- 1747US2012148566A1Product and method for treatment of conditions associated with receptor-desensitizationVILEN BARBARA J·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John C. Cambier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →